As shown in Figure 5, the frequency of Th17 in peripheral blood mononuclear cells decreased significantly in DSS-treated WT mice after receiving BM-MDSCs, implying that MDSCs may protect mice from DSS-colitis via suppressing the frequencies of IL-17-producing Th17 cells. Here, IL17A is linked to colitis.